THRX — Theseus Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $181.72m
- -$23.40m
- 42
- 36
- 15
- 21
Annual cashflow statement for Theseus Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -7.18 | -12 | -27.3 | -50.6 |
| Depreciation | ||||
| Non-Cash Items | 2.55 | 6.21 | 4.36 | 11.1 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -0.179 | 0.933 | -4.25 | 6.55 |
| Change in Prepaid Expenses | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Cash from Operating Activities | -4.81 | -4.85 | -27.2 | -32.9 |
| Capital Expenditures | — | — | — | -0.455 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | 0 | 0 | 0 | -117 |
| Sale/Maturity of Investment | ||||
| Change in Net Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | 0 | 0 | 0 | -117 |
| Financing Cash Flow Items | — | — | -3.75 | 0 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Cash from Financing Activities | 2.99 | 12 | 264 | 0.182 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -1.81 | 7.14 | 237 | -150 |